Jens Schlegel Email and Phone Number
One of the keys to success throughout my career has been building strong, mutually beneficial relationships. I welcome the opportunity to share advice & guidance with others in the LinkedIn community. Please reach out for a chat involving strategic CMC leadership, drug manufacturing and product development, client and commercial products, and regulatory compliance.Ways that I contribute my expertise:➨ Serving as a culturally astute, results-focused, pragmatic visionary and director of chemistry, manufacturing, and controls.➨ Applying proven global experience in API development, organic chemistry, small molecule processes, and organic compounds. ➨ Applying proven global experience in Formulation development, scale up and commercialization, Tech Transfers and validation➨ Spearheading process optimization, product creation, commercialization, tech transfer, and regulatory compliance.➨ Demonstrating an entrepreneurial spirit, ambition, and organizational skills.➨ Navigating ambiguity while guiding organizations through uncertainty and necessary change. ➨ Employing intellectual curiosity, optimism, and a collaborative approach in decision-making.➨ Interacting with corporate executives, clients, multicultural global partners, and research and development personnel.➨ Acting as a team player to inspire harmonious business relationships.➨ Forging productive alliances, managing conflict, and contributing to the larger whole of organizations.➨ Mentoring and coaching, communicating effectively, and overseeing multiple complex priorities.➨ Thriving in demanding and fast-paced environments.Please feel free to reach out to me directly via LinkedIn or docsschlegel@yahoo.com.
Rapid Pharma Development Gmbh
View-
ConsultantCmc Consulting Schlegel Oct 2023 - PresentBaar, Zug, Switzerland
-
Associate DirectorRapid Pharma Development Gmbh Jan 2024 - PresentBaar, Zug, Switzerland -
Head Cmc GlobalPhoenixus Ag Apr 2018 - Jan 2024Zürich Area, SwitzerlandWhile in this role, I promote products mainly to the US, with an initiative in progress to expand into the European Union. I’ve conceptualized and devised new treatments for toxoplasmosis gondii and orphan indications where no medical treatment is available today. Lastly, I retain several onsite research and development department collaborating with external partners.My most notable achievements: ➜ Delivered 50% cost savings for late-stage development after outsourcing and directing the existing and new active pharmaceutical ingredients (API) and drug product (DP) formulation activities from the pre-clinical to the commercial phase.➜ Supplied present/future value CMC information (execution m2 and m3 module) by creating the documentation for investigational new drugs (IND) to support the FDA approval for clinical studies for three programs.➜ Expanded operations across four sites by assessing and incorporating new contract manufacturing organizations (CMOs).➜ Obtained approval for programs enabling the product to undergo clinical trials and be commercialized by developing processes, devising analytical methods, and organizing experimental designs.➜ Averted potential fines/censures stock out situations or supply interruptions by supporting QA and RA and external partners during quality investigations and routine production.
-
Head Technical AllianceTillotts Pharma Ag Mar 2013 - Mar 2018Rheinfelden, Aargau, SwitzerlandAs the head of the technical alliance, I revolutionized the origination of pharmaceutical products in the gastroenterology field. I served as the single point of contact between the company and external global API and drug product manufacturers. I also led a five-person interdisciplinary staff responsible for a budget, purchasing APIs, outsourcing DP processes, and troubleshooting. I secured a reliable supply of products, implemented new API sources and DP sites, and supported API and DP-focused R&D activities with cross-functional teams. High-level successes include: ➜ Spearheaded a multi-million-CHF project and a cross functional team while acquiring new drug product and completing the drug’s tech transfer from an existing supplier to a new CMO.➜ Obtained approval for programs enabling the product to undergo clinical trials, be commercialized, and opened a second manufacturing site for supply security after transferring and validating a five intermediate drug product formulation process.➜ Secured approval from European countries within five years, ensuring uninterrupted supply after acquiring a product for manufacturing by leading the auditing, technology transfer, validation, and supporting submission of information to regulatory authorities.➜ Attained European approval for a 2nd manufacturing site for existing products by investigating the production problems, implementing process improvements, and completing process validation.➜ Surpassed the scheduled period by 12 months for implementing the new ICH guidelines Q3D by proactively incorporating all external manufacturing partners, API, and drug product sites, including collecting data and conducting analytical testing. -
Head Chemical DevelopmentRohnerchem Jun 2011 - Feb 2013PrattelnAs the head of research and development, I managed and supervised a team of 20, focusing on chemical development, technical transfer of the processes, and production support. Additionally, I directed a range of tasks, including API and intermediates, fine chemicals, and building blocks to monomers and polymers, the entire spectrum of organic compounds from pharmaceutical, agricultural, textile, and specialties of the electronic industries. Lastly, I managed several personnel issues to create a more stable department and integrated standard management tools for resource planning, timeline control, and project budgeting.Noteworthy achievements include the following:➜ Engineered to secure a multi-million CHF program by effectively establishing corporate trust through completing a high-value project with a new customer, where trials showcased collaborative efforts and exceptional performance.➜ Doubled the capacity efficiency by transitioning from single to parallel reaction steps, allowing for up to 35 per week change in people’s mindset and laboratory technology while handling new and ongoing initiatives and processing customer samples.➜ Won requests for proposals, demonstrating excellent financial and quality performance for customers by creating a marketing strategy to provide samples to desired specifications and utilizing cost-effective synthetic route ideas that simplified production.
-
Head Chemical Development At Siegfried LtdSiegfried Ltd Jul 2006 - May 2011
Jens Schlegel Education Details
-
University Of UlmChemistry
Frequently Asked Questions about Jens Schlegel
What company does Jens Schlegel work for?
Jens Schlegel works for Rapid Pharma Development Gmbh
What is Jens Schlegel's role at the current company?
Jens Schlegel's current role is Chemistry, Manufacturing, & Controls (CMC) Executive – Spearheading Process Optimizations, Expertly Scaling Up & Validation Processes for APIs/Products, Validating Analytical Methods, QA, QP, FvP, Consultant.
What schools did Jens Schlegel attend?
Jens Schlegel attended University Of Ulm.
Not the Jens Schlegel you were looking for?
-
-
-
Jens Schlegel
Schkeuditz -
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial